Balram Bhargava

Third nationwide sero-survey shows that large population still vulnerable to COVID-19, says ICMR

Director Dr Balram Bhargava also said that over 21 percent of the population, aged 10 years and above, showed evidence of exposure to COVID-19

Three COVID-19 reinfection cases identified, says ICMR; two in Mumbai and one in Ahmedabad

The ICMR chief on Tuesday said that India is taking 100 days as the cut-off period in the identification of reinfection of novel coronavirus cases

Every 15th person exposed to virus by Aug, reveals second sero-survey; COVID-19 risk double in urban slums

The risk of exposure to the virus in urban slums was twice that of the risk in non-slum urban areas and four times the risk in rural settings, said ICMR DG Balram Bhargava

Hard to predict likelihood of second wave of COVID-19 infections in India, ICMR DG says as case tally crosses 18 lakh

ICMR reportedly co-developed a platform with other 10 Southeast Asian countries to conduct collaborative research on emerging diseases.

Use hydroxychloroquine for high-risk COVID-19 cases, recommends ICMR; drug to be used only as preventive measure: All you need to know

Hydroxychloroquine is an oral prescription drug that is primarily used to treat some kinds of malaria. However, some recent studies have indicated that it may also be useful to treat COVID-19.

India to allow NABL-accredited private labs to conduct coronavirus testing; ICMR appeals facilities to offer diagnosis at 'no cost'

There are 72 functional Indian Council of Medical Research (ICMR) laboratories conducting tests for coronavirus, ICMR director general Balram Bhargava said.